Shanghai, China

Hua Medicine (shanghai) Ltd.


Patents = 13

Forward Citations = 5


where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents


15 inventors (with patents filed for the assignee):


Hua Medicine (Shanghai) Ltd. is a clinical-stage biopharmaceutical company developing a portfolio of novel, innovative therapies for the treatment of diabetes and CNS disorders. Their lead product is dorzagliatin, a first-in-class, glucokinase activator for the treatment of type 2 diabetes. Hua Medicine is committed to improving patient outcomes and quality of life by leveraging cutting-edge science and technology.
This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com
Loading…